Investment Summary

Icos Capital Invests In NapiFeryn

On January 30, 2024, growth capital firm Icos Capital invested in life science company NapiFeryn

Investment Highlights
  • This is Icos Capital’s 2nd transaction in the Life Science sector.
  • This is Icos Capital’s 1st transaction in Poland.

Investment Summary

Date 2024-01-30
Target NapiFeryn
Sector Life Science
Investor(s) Icos Capital
Deal Type Growth Capital

Target

NapiFeryn

Lodz, Poland
NapiFeryn is a innovator that developed and patented a unique technology for obtaining rapeseed protein from the side-streams of oil pressing. NapiFeryn was founded in 2014 and is based in Lodz, Poland.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

DESCRIPTION

Icos Capital is a specialist private equity firm focused on investments in clean technology. Icos looks for European companies that offer new, alternative scarce resources (water, energy) and more efficient industrial and consumer products. The firm looks to provide growth capital in the form of minority investments. Icos' target investment size is €1 to €5 million. Icos Capital is headquartered in Rotterdam, Netherlands.


DEAL STATS #
Overall 14 of 16
Sector: Life Science M&A 2 of 3
Type: Growth Capital M&A Deals 11 of 13
Country: Poland M&A 1 of 1
Year: 2024 M&A 2 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2024-01-18 Fotoniq

Delft, Netherlands

Fotoniq is a provider of the sprayable PAR+ coating that creates optimal daylight conditions inside of greenhouses. Fotoniq was founded in 2021 and is based in Delft, Netherlands.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-08-16 PEF Technologies

Enschede, Netherlands

PEF Technologies offers a wide range of food processing equipment for various needs of businesses of any level of production. PEF Technologies's nanoPEF is a completely new low-temperature food preservation technology. PEF Technologies was founded in 2018 and is based in Enschede, Netherlands.

Buy -